Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Synagis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Synagis was produced by AstraZeneca and AbbVie.

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

FDA clears Sobi’s Gamifant for ‘hyper-inflammation’ disease

Earlier this month, Sobi agreed to acquire the US rights to AstraZeneca’s respiratory syncytial virus (RSV) prevention drug Synagis (palivizumab) in a deal worth $1.5bn. ... Sobi's Guido Oelkers. “Gamifant will add significant strength to Sobi’s

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi

AZ cuts $1.5bn-plus deal to pass US drug rights to Sobi s focus on Synagis will enable infants in the US to continue benefiting from this important treatment.”. ... The addition of Synagis will become an important strategic catalyst for Sobi’s future development and will form a powerful platform for

Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi

Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi AZ sells a prophylactic RSV antibody - Synagis (palivizumab) - which brought in $677m in sales in 2016 despite being reserved for use in high-risk infants.

Regeneron drops RSV drug

Regeneron drops RSV drug At the moment the only approved prophylaxis against the virus is AZ's Synagis (palivizumab) which brought in $677m in sales last year. ... Synagis has previously been a $1bn-plus product, but has seen its sales shrink thanks to the start of generic

Sanofi buys into AZ drug for preventing RSV infections

Sanofi buys into AZ drug for preventing RSV infections The deal also includes up to 495m in development and sales milestone payments and focuses on MEDI8897, a follow-up to AZ's already-marketed Synagis (palivizumab) which is the first ... Synagis brought in $677m in sales for AZ last year, with sales down

1 2 3 4 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics